Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study suggests physicians and patients overestimate asthma control

Key clinical point: New data suggest physicians and patients both overestimate control of severe asthma.

Major finding: More than half (53%) of cases physicians rated as controlled were actually uncontrolled according to the Asthma Control Test, and 30% of patients who considered their asthma controlled actually were uncontrolled according to the test.

Study details: Observational study of 482 evaluable subjects

Disclosures: The study is supported by AstraZeneca. Dr. Panettieri disclosed relationships with AstraZeneca, Sanofi, Regeneron, Genentech, and Novartis.

Citation:

Panettieri R et al. CHEST 2019. Abstract, doi. 10.1016/j.chest.2019.08.272.